| __timestamp | Catalyst Pharmaceuticals, Inc. | Supernus Pharmaceuticals, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 10117774 | 19586000 |
| Thursday, January 1, 2015 | 11801342 | 29135000 |
| Friday, January 1, 2016 | 11369941 | 42791000 |
| Sunday, January 1, 2017 | 11375237 | 49577000 |
| Monday, January 1, 2018 | 19919204 | 89209000 |
| Tuesday, January 1, 2019 | 18842752 | 69099000 |
| Wednesday, January 1, 2020 | 16496715 | 75961000 |
| Friday, January 1, 2021 | 16936000 | 90467000 |
| Saturday, January 1, 2022 | 19789000 | 74552000 |
| Sunday, January 1, 2023 | 93150000 | 91593000 |
Unlocking the unknown
In the competitive landscape of pharmaceuticals, research and development (R&D) is the lifeblood of innovation. Over the past decade, Catalyst Pharmaceuticals, Inc. and Supernus Pharmaceuticals, Inc. have demonstrated contrasting strategies in their R&D investments. From 2014 to 2023, Supernus consistently outpaced Catalyst in R&D spending, with an average annual investment nearly three times higher. However, 2023 marked a pivotal year as Catalyst's R&D expenditure surged by over 370%, nearly matching Supernus's investment. This dramatic increase suggests a strategic pivot by Catalyst, potentially signaling new product developments or expansions. Meanwhile, Supernus maintained a steady growth trajectory, underscoring its commitment to sustained innovation. As these two companies continue to evolve, their R&D investments will be crucial in shaping their competitive edge and market impact.
Research and Development Investment: Johnson & Johnson vs Catalyst Pharmaceuticals, Inc.
Comparing Innovation Spending: Gilead Sciences, Inc. and Catalyst Pharmaceuticals, Inc.
R&D Insights: How Zoetis Inc. and Supernus Pharmaceuticals, Inc. Allocate Funds
Who Prioritizes Innovation? R&D Spending Compared for Insmed Incorporated and Supernus Pharmaceuticals, Inc.
R&D Insights: How Bio-Techne Corporation and Catalyst Pharmaceuticals, Inc. Allocate Funds
Research and Development Investment: Pharming Group N.V. vs Catalyst Pharmaceuticals, Inc.
Who Prioritizes Innovation? R&D Spending Compared for Corcept Therapeutics Incorporated and Catalyst Pharmaceuticals, Inc.
Alkermes plc vs Supernus Pharmaceuticals, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Alpine Immune Sciences, Inc. and Supernus Pharmaceuticals, Inc.
Comparing Innovation Spending: CymaBay Therapeutics, Inc. and Catalyst Pharmaceuticals, Inc.
Analyzing R&D Budgets: Vericel Corporation vs Supernus Pharmaceuticals, Inc.
Research and Development: Comparing Key Metrics for Catalyst Pharmaceuticals, Inc. and Evotec SE